Julien Calvo

Fontenay-sous-bois, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Orchestration of human multi-lineage hematopoietic cell development by humanized in vivo bone marrow models.

Orchestration of human multi-lineage hematopoietic cell development by humanized in vivo bone marrow models.

Journal: HemaSphere

Published: September 20, 2024

T-cell acute lymphoblastic leukemia progression is supported by inflammatory molecules including hepatocyte growth factor.

T-cell acute lymphoblastic leukemia progression is supported by inflammatory molecules including hepatocyte growth factor.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 30, 2024

High CD44 expression and enhanced E-selectin binding identified as biomarkers of chemoresistant leukemic cells in human T-ALL.

High CD44 expression and enhanced E-selectin binding identified as biomarkers of chemoresistant leukemic cells in human T-ALL.

Journal: Leukemia

Published: April 12, 2024

Identifying Candidate Gene Drivers Associated with Relapse in Pediatric T-Cell Acute Lymphoblastic Leukemia Using a Gene Co-Expression Network Approach.

Identifying Candidate Gene Drivers Associated with Relapse in Pediatric T-Cell Acute Lymphoblastic Leukemia Using a Gene Co-Expression Network Approach.

Journal: Cancers

Published: January 18, 2024

The AXL inhibitor bemcentinib overcomes microenvironment-mediated resistance to pioglitazone in acute myeloid leukemia.

The AXL inhibitor bemcentinib overcomes microenvironment-mediated resistance to pioglitazone in acute myeloid leukemia.

Journal: The FEBS journal

Published: October 20, 2023

β-Catenin and its new partner FOXO3 shake T-ALL.

β-Catenin and its new partner FOXO3 shake T-ALL.

Journal: Blood

Published: March 30, 2023

A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors.

A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors.

Journal: Communications biology

Published: February 17, 2023

CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia.

CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia.

Journal: Nature communications

Published: May 06, 2021

Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia.

Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia.

Journal: Molecular oncology

Published: July 24, 2020

Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop.

Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop.

Journal: Blood advances

Published: June 30, 2020

Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia.

Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia.

Journal: Cancer discovery

Published: December 10, 2019

Desperately seeking a home marrow niche for T-cell acute lymphoblastic leukaemia.

Desperately seeking a home marrow niche for T-cell acute lymphoblastic leukaemia.

Journal: Advances in biological regulation

Published: June 24, 2019

Showing 1-12 of 28

Last Updated: 09/26/2026